Missouri SB1724 classifies xylazine as a Schedule III controlled substance.
Missouri SB1724 modifies the classification of xylazine, placing it in Schedule III of controlled substances. This bill defines the criteria for substances in Schedule III, including their potential for abuse, accepted medical use, and the level of physical or psychological dependence they may cause. The bill also outlines the procedures for scheduling substances and the exemptions that may be granted by the Department of Health and Senior Services.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.